AIHealthcare Analytics

Knowledge Wiki

Bot vs. Bot — AI Arms Race in Prior Authorization and Appeals

CONCEPT
Rev 11 Jul 21, 2026 12:44 UTC 0 sources

Content

Overview

The deployment of AI by both health insurers and provider organizations for prior authorization, claims submission, and appeals has created a self-reinforcing "bot vs. bot" dynamic that is driving up administrative costs across the healthcare system — a phenomenon now attracting significant industry and policy attention.

HSS Perspective: The Cost Spiral

MedCity News reported on HSS chief digital and information officer Ashis Barad, who has worked on both payer and provider sides of healthcare AI, arguing that the industry's growing bot vs. bot battle over prior authorizations and appeals is driving costs up for all parties (Art. 62). Barad's proposed solution is data sharing between providers and payers to build more personalized care pathways that reduce the volume of contested authorization decisions in the first place.

Mark Cuban's Warning

Mark Cuban has publicly warned that AI in healthcare will primarily help insurers "delay and deny" claims more efficiently, firing back at Marc Andreessen's claim that AI would function as a democratizing personal physician (Art. 16). Cuban's critique frames AI-powered prior authorization as a tool for cost shifting onto patients rather than genuine care improvement — a perspective that aligns with the bot vs. bot dynamic Barad describes.

Policy and Structural Implications

The bot vs. bot dynamic represents a systemic failure mode: both sides invest in AI to win zero-sum administrative battles, with costs ultimately borne by patients and employers through premiums. Peterson Health Technology Institute's report on clinical AI payment models (referenced in Art. 59) argues that current payment structures actively incentivize this dynamic by rewarding administrative volume rather than clinical outcomes.


Contradictions

Prior Claim
The bot vs. bot dynamic in prior authorization is primarily a provider-payer efficiency problem with neutral cost implications.
New Claim
HSS CDIO Ashis Barad and MedCity News reporting characterize the bot vs. bot battle as actively driving costs up for all parties — including patients — making it a systemic cost inflation mechanism rather than a neutral efficiency dynamic.
Detected Jul 21, 2026 12:40 UTC

Related Pages

Revision History (11 revisions)
Rev 11 Jul 21, 2026 12:44 UTC
Rev 10 Jul 21, 2026 10:24 UTC
Rev 9 Jul 21, 2026 06:24 UTC
Rev 8 Jul 21, 2026 02:23 UTC
Rev 7 Jul 20, 2026 22:27 UTC
Rev 6 Jul 20, 2026 14:07 UTC
Rev 5 Jul 20, 2026 12:43 UTC
Rev 4 Jul 20, 2026 08:42 UTC
Rev 3 Jul 20, 2026 04:42 UTC
Rev 2 Jul 20, 2026 04:02 UTC
Rev 1 Jul 19, 2026 21:25 UTC
← Back to Wiki Index